PI3K (delta) selective inhibitors

Details for Australian Patent Application No. 2010300719 (hide)

Owner Tyrogenex, Inc.

Inventors Liang, Congxin

Agent Griffith Hack

Pub. Number AU-A-2010300719

PCT Pub. Number WO2011/041399

Priority 61/277,737 29.09.09 US

Filing date 29 September 2010

Wipo publication date 7 April 2011

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/52 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 473/02 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/041399 Priority application(s): WO2011/041399

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010300721-Improved heavy metals trapping cocatalyst for FCC processes

2010300713-Genes, methods, and compositions related to neurogenesis and its modulation